Anti-CD20 therapy of ocular disorders

Details for Australian Patent Application No. 2004270165 (hide)

Owner Genentech, Inc.

Inventors Brunetta, Paul G.

Agent Griffith Hack

Pub. Number AU-A-2004270165

PCT Pub. Number WO2005/023302

Priority 60/498,791 29.08.03 US

Filing date 20 August 2004

Wipo publication date 17 March 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/023302 Priority application(s): WO2005/023302

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270166-N3 alkylated benzimidazole derivatives as MEK inhibitors

2004270163-Preloaded IOL injector